The Gene Synthesis Industry at Work
The Promotion of Biosecurity
In September of 2009, five of the world's leading gene synthesis companies came together to form the IGSC. By screening the sequences of synthetic gene orders and the customers who place them, the companies aim to support government efforts to prevent the misuse of gene synthesis technology.
Blue Heron Biotechnology, DNA2.0, GENEART, GenScript and Integrated DNA Technologies together represent approximately 80 percent of the global gene synthesis capacity. They have formed the International Gene Synthesis Consortium (IGSC) to coordinate ongoing best practices development and to work together with governments and others concerned to promote the beneficial application of gene synthesis technology and to safeguard biosecurity.
- International Gene Synthesis Consortium Forms Not-for-Profit
Menlo Park, CA. April 28, 2015 The International Gene Synthesis Consortium (IGSC), an association of the world’s leading gene synthesis companies, today announced that it has established itself as a not-for-profit U.S. corporation. The move is intended to make it easier for the organization to welcome new members... Read More
- WORLD’S TOP GENE SYNTHESIS COMPANIES ESTABLISH TOUGH BIOSECURITY SCREENING PROTOCOL
Washington D. C., November 19, 2009—Five of the world’s leading gene synthesis companies today announced agreement that they will apply a common screening protocol to promote biosecurity in the gene synthesis industry. By screening the sequences of synthetic gene orders...Read More
- Harmonized Screening Protocol - Gene Sequence & Customer Screening to Promote Biosecurity
This document outlines the standards and practices that IGSC gene synthesis companies apply to prevent the misuse of synthetic genes. By screening the sequences of ordered genes and vetting customers, IGSC companies help to ensure that science and industry realize the many benefits of gene synthesis technology while minimizing risk...Read More
- Preventing the misuse of gene synthesis
To the Editor:
As representatives of two companies— GENEART and DNA2.0—that together are responsible for a majority of the world’s manufacture of synthetic genes, we feel compelled to respond to Nouri and Chyba’s proposition for “proliferation-resistant biotechnology,” as published in the March issue...Read More